Overview

Impact of Genetics on Metformin Pharmacokinetics

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Specific Aims: To compare metformin pharmacokinetics in monozygotic and dizygotic twin pairs. Comparing renal clearance of metformin in monozygotic and dizygotic twins will allow us to better understand the influence of heredity on variation in renal elimination. Furthermore, genotyping renal transporter genes in monozygotic and dizygotic twin pairs with significant differences in renal clearance of metformin may give us insight into the genes responsible for this variability.
Phase:
N/A
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Metformin